Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBk. Cyprus Hldg Regulatory News (BOCH)

Share Price Information for Bk. Cyprus Hldg (BOCH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 320.00
Bid: 321.00
Ask: 322.00
Change: -1.00 (-0.31%)
Spread: 1.00 (0.312%)
Open: 322.00
High: 322.00
Low: 320.00
Prev. Close: 321.00
BOCH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update on Project Helix

19 Mar 2019 15:16

RNS Number : 3441T
Bank of Cyprus Holdings PLC
19 March 2019
 

Announcement

 

Update on Project Helix - Agreement for the sale of a portfolio of non-performing loans

 

 

Nicosia, 19 March 2019

 

 

 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014

 

 

Further to the announcement of 28 August 20181 in relation to the agreement for the sale of a portfolio of non-performing loans, known as "Project Helix", or the "Transaction", Bank of Cyprus Holdings Public Limited Company ("BOCH" and, together with its subsidiaries, the "Group") announces that it has received approval from the ECB for the Significant Risk Transfer ("SRT") benefit from the Transaction.

This is an important step towards completion of the Transaction, which remains subject to various outstanding conditions precedent1. Completion is currently expected to occur in early 2Q2019.

As previously reported, the Transaction reduces the Group's non-performing exposures (NPEs) by €2.7 bn and improves the NPE ratio from 47% to 36%3. The NPE provisioning coverage ratio pro forma for the Transaction stands at 47%3.

On completion, the derecognition of the Helix portfolio is expected to have a positive impact on the capital ratios of 160 basis points2, resulting from the release of risk weighted assets.

As at 31 December 2018, as previously reported, the Group's phased-in CET1 ratio and Total capital ratio, pro forma for both DTC2 and Helix, stood at 15.4% and 18.3% respectively.

For further information, please contact Investor Relations at investors@bankofcyprus.com.

[1] Further to the announcement of 28 August 2018 and updates provided with the publication of the Group financial results for the nine months ended 30 September 2018 and the preliminary Group financial results for the year ended 31 December 2018

2 Refer to slide 36 of the presentation for the preliminary Group financial results for the year ended 31 December 2018 published on 4 March 2019

3 Based on the preliminary Group financial results for the year ended 31 December 2018

4 DTC refers to the amendments in the legislation adopted by the Cyprus Parliament on 1 March 2019 and was published on the Official Gazette of the Republic on 15 March 2019

 

 

Group Profile

 

The Bank of Cyprus Group is the leading banking and financial services group in Cyprus, providing a wide range of financial products and services which include retail and commercial banking, finance, factoring, investment banking, brokerage, fund management, private banking, life and general insurance. The Bank of Cyprus Group operates through a total of 112 branches in Cyprus. Bank of Cyprus also has representative offices in Russia, Ukraine and China. The Bank of Cyprus Group employs 4,146 staff worldwide. At 31 December 2018, the Group's Total Assets amounted to €22.1 bn and Total Equity was €2.4 bn. The Bank of Cyprus Group comprises Bank of Cyprus Holdings Public Limited Company, its subsidiary Bank of Cyprus Public Company Limited and its subsidiaries.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
FURLLFLEVVIALIA
Date   Source Headline
12th Jun 20238:39 amRNSPDMR Notification of Transaction – Iordanou
8th Jun 20239:01 amRNSDoc re. (Investor Presentation Update)
8th Jun 20239:00 amRNSAnnouncement for the Investor Update Event
30th May 20237:00 amRNSTR1 Notification of Major Holdings -Eaton Vance
26th May 20235:57 pmRNSResult of AGM-Replacement
26th May 202312:41 pmRNSBoard Election and Board Committees composition
26th May 202312:35 pmRNSResolutions of AGM
16th May 20237:01 amRNSDoc re. (1Q2023 Investor Presentation)
16th May 20237:00 amRNS1Q2023 Group Financial Results
11th May 20238:56 amRNSInvestor Update event scheduled for 8 June 2023
9th May 202312:24 pmRNSAppointment of Additional Corporate Broker
5th May 20239:16 amRNSDate of announcement of 1Q2023 FR
25th Apr 202310:52 amRNSNotice of AGM 2023
19th Apr 20237:06 amRNSTR1 Notification of Holdings -Eaton Vance
13th Apr 20231:44 pmRNSResumption of dividend payments
5th Apr 202311:51 amRNSDoc re. (2022 Pillar 3 Disclosures)
3rd Apr 202310:07 amRNSChanges in the composition of the Boards
31st Mar 202312:54 pmRNSBOC Annual Financial Report 2022 Announcement
31st Mar 202312:50 pmRNSBOCH Annual Financial Report 2022 Announcement
31st Mar 202312:49 pmRNSFY2022 Group Financial Results
31st Mar 202312:46 pmRNSDoc re. (FY2022 Investor Presentation)
21st Mar 202311:02 amRNSDate of announcement of the Audited FR FY2022
20th Feb 202312:12 pmRNSNomination for appoint. to the Board of Directors
20th Feb 20237:04 amRNSPreliminary FY2022 Group Financial Results
20th Feb 20237:02 amRNSDoc re. (Prelim FY2022 Investor Presentation)
8th Feb 20237:04 amRNSAppointment of Additional Corporate Broker
3rd Feb 202310:51 amRNSDate of announcement of PrelimFY2022 FR
9th Jan 20237:00 amRNSTR1 Notification of Major Holdings -Senvest
30th Dec 20227:33 amRNSLong Term Incentive Plan
23rd Dec 20229:15 amRNSPDMR Notification of Transaction – Iordanou
16th Dec 20221:54 pmRNSExtension of appointment of Group CEO
16th Dec 20228:05 amRNSDate of Annual General Meeting
12th Dec 20227:14 amRNSEU-wide Transparency Exercise 2022
30th Nov 20227:28 amRNSChange in the composition of the Board Committees
25th Nov 20229:36 amRNSPDMR Notification of Transaction – Arapoglou
24th Nov 20229:13 amRNSPDMR Notification of Transaction – Arapoglou
23rd Nov 20229:12 amRNSPDMR Notification of Transaction – Arapoglou
22nd Nov 202210:20 amRNSPDMR Transaction - Arapoglou
18th Nov 202210:26 amRNSCompletion of Project Helix 3
18th Nov 20227:01 amRNS9M2022 Investor Presentation Announcement
18th Nov 20227:00 amRNS9M2022 Group Financial Results
16th Nov 20229:01 amRNSBOCH Explanation following its AGM on 20 May 2022
4th Nov 20229:09 amRNSDate of announcement of 9M2022 FR
27th Oct 20227:00 amRNSChange in the composition of the Board Committees
5th Oct 202211:38 amRNSTR1- Provident Fund of the Cyprus Bank Employees
3rd Oct 20224:41 pmRNSSecond Price Monitoring Extn
3rd Oct 20224:35 pmRNSPrice Monitoring Extension
30th Sep 20228:59 amRNSForm 38.5 (EPT/RI)
29th Sep 20228:55 amRNSForm 38.5 (EPT/RI)
28th Sep 202211:41 amRNSForm 38.5b - Bank of Cyprus Holdings PLC

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.